v3.22.4
License Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Sep. 30, 2017
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2022
May 31, 2020
Related Party Transaction [Line Items]          
Revenue recognized   $ (2,831) $ (1,264)    
Kyowa Kirin Co          
Related Party Transaction [Line Items]          
Total upfront payment receivable for grant of rights         $ 100,000
Presage License Agreement | Presage Biosciences, Inc.          
Related Party Transaction [Line Items]          
Compensation payable for grant of rights $ 4,900        
Payment for license 2,900        
Presage License Agreement | Presage Biosciences, Inc. | Incremental Payment          
Related Party Transaction [Line Items]          
Compensation payable for grant of rights 2,000        
Presage License Agreement | Presage Biosciences, Inc. | Potential Payments on Achievement of Development Regulatory and Commercial Milestones          
Related Party Transaction [Line Items]          
Milestone payment receivable amount $ 179,000        
Kkc Agreements [Member] | Kyowa Kirin Co          
Related Party Transaction [Line Items]          
Upfront payment   100,000      
Transaction price relating to the performance obligation   216,300      
Expected milestone payment receivable   20,000      
Estimated development cost sharing recovered through earnings   91,100      
Deferred revenue   5,200      
Revenue recognized   16,600      
Revenue related to non-refundable payments for performance obligations   8,600      
Kkc Agreements [Member] | Kyowa Kirin Co | Ex US License          
Related Party Transaction [Line Items]          
Revenue recognized   21,000      
License Obligation Account Transaction Price Allocated   64,500      
Kkc Agreements [Member] | Kyowa Kirin Co | Development Services          
Related Party Transaction [Line Items]          
Contract with customer liability non current   2,900   $ 30,900  
Kkc Agreements [Member] | Kyowa Kirin Co | Maximum          
Related Party Transaction [Line Items]          
Estimated development cost sharing recovered through earnings   $ 143,800